Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Matthew, Regulski"'
Publikováno v:
Antibiotics, Vol 12, Iss 3, p 536 (2023)
Considering the prevalence and pathogenicity of biofilms in wounds, this study was designed to evaluate the anti-biofilm capabilities of eight commercially available wound care products using established in vitro assays for biofilms. The products eva
Externí odkaz:
https://doaj.org/article/f751968a55024ef3962346418e54e908
Publikováno v:
Reports, Vol 5, Iss 3, p 28 (2022)
The management of diabetic foot ulcers (DFUs) presents challenges to even the most experienced wound-care providers. Because of the chronic, non-healing nature of many DFUs, advances in the treatment and care of this disease process are particularly
Externí odkaz:
https://doaj.org/article/14862940f1f94919b3fa2a04d5710320
Publikováno v:
Journal of Biomedical Research & Environmental Sciences. 3:1007-1011
Chronic Venous Insufficiency (CVI) is a lifelong, moribund and debilitating disease process with tremendous personal and financial costs. At its core, CVI involves blood pooling in the lower extremities secondary to inadequate venous blood return, re
Chronic venous insufficiency (CVI) is a lifelong, moribund, and debilitating disease process with tremendous personal and financial costs. At its core, CVI involves blood pooling in the lower extremities secondary to inadequate venous blood return, r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55585110fc40b80475641349ba48c489
Publikováno v:
Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair SocietyREFERENCES. 29(5)
Patients with a diabetic foot ulcer (DFU) suffer disabilities and are at increased risk for lower extremity amputation. Current standard of care includes debridement, topical antibiotics, and weight off-loading-still resulting in low rates of healing
Autor:
Lawrence, Lavery, James, Fulmer, Karry Ann, Shebetka, Matthew, Regulski, Dean, Vayser, David, Fried, Howard, Kashefsky, Tammy M, Owings, Janaki, Nadarajah, Zoe, Hesp
Publikováno v:
Wounds : a compendium of clinical research and practice. 30(9)
The results of the single-arm, open-label extension phase of the Grafix (cryopreserved placental membrane; CPM; Osiris Therapeutics, Inc, Columbia, MD) multicenter, blinded, randomized, controlled clinical trial for chronic diabetic foot ulcers (DFUs
Autor:
Matthew, Regulski
Publikováno v:
Wounds : a compendium of clinical research and practice. 30(4)
This study examines the healing dynamics of in vivo porcine muscle tissue wounds hemostatically treated with a saline-coupled bipolar tissue sealer (SCBS) compared with traditional electrosurgical (ES) coagulation.Six cutaneous incisions were created
Autor:
Matthew, Regulski
Publikováno v:
Wounds : a compendium of clinical research and practice. 30(3)
ntroduction. Chronic nonhealing wounds are a growing health care problem in the United States, afflicting more than 6.5 million patients annually. In particular, diseases that compromise skin integrity and impair normal wound healing processes, such
Autor:
Lawrence A, Lavery, James, Fulmer, Karry Ann, Shebetka, Matthew, Regulski, Dean, Vayser, David, Fried, Howard, Kashefsky, Tammy M, Owings, Janaki, Nadarajah, Ian, Gordon
Publikováno v:
International Wound Journal
In a randomised, controlled study, we compared the efficacy of Grafix®, a human viable wound matrix (hVWM) (N = 50), to standard wound care (n = 47) to heal diabetic foot ulcers (DFUs). The primary endpoint was the proportion of patients with comple
Autor:
Matthew, Regulski, Douglas A, Jacobstein, Russell D, Petranto, Vincent J, Migliori, Girish, Nair, Darelle, Pfeiffer
Publikováno v:
Ostomy/wound management. 59(12)
Despite the introduction of advanced wound care modalities over the last 15 years, chronic wounds are an increasing problem. Few single options are available for clinicians to treat recalcitrant wounds such as diabetic foot ulcers (DFUs) and venous l